8C99C7EA.png
  • GV-971
    • Product overview
    • China Phase III Clinical Trial
    • Mechanism of Action
    • Clinical Guideline
    • Q&A
  • Scientific Research Information
    • GREEN MEMORY
    • Post-marketing Study
    • IIR Program
    • Relevant Literature
  • Information and Services
    • Master e-Classes
    • Typical Case
    • Case Study
    • Assessment Scale
    • Conference Information
    • News Reports
    • Pharmacovigilance
  • Company Website
CN
8C99C7EA.png
CN
  • GV-971
    • Product overview
    • China Phase III Clinical Trial
    • Mechanism of Action
    • Clinical Guideline
    • Q&A
  • Scientific Research Information
    • GREEN MEMORY
    • Post-marketing Study
    • IIR Program
    • Relevant Literature
  • Information and Services
    • Master e-Classes
    • Typical Case
    • Case Study
    • Assessment Scale
    • Conference Information
    • News Reports
    • Pharmacovigilance
  • Company Website
021-50540520
pvg-banner.png banph3.jpg

Information and Services

INFORMATION

  • Master e-Classes
  • Typical Case
  • Case Study
  • Assessment Scale
  • Conference Information
  • News Reports
  • Pharmacovigilance
Master e-Classes
Master e-Classes
Typical Case
Case Study
Assessment Scale
Conference Information
News Reports
Pharmacovigilance
Your location:
  • Home
  • Information and Services
  • Master e-Classes

Master e-class invites global professors in the field of neurology and brain sciences to deliver lecture on Alzheimer's disease, GV-971, brain-gut axis, neuro-inflammation and others.

  • Sun Jing
    Chief Physician of the Department of Neurology at the Second Affiliated Hospital of Wenzhou Medical University.
    2022-06-17
    The Gut Microbiota and Alzheimer’s Disease
  • Li Xiaofeng
    Chief Physician of the Department of Neurology at the Second Affiliated Hospital of Chongqing Medical University.
    2022-06-17
    Building the Bridge between Doctors and AD Patients
  • Peng Guoping
    Chief Physician of the Department of Neurology at the First Affiliated Hospital, Zhejiang University School of Medicine.
    2022-06-17
    LATE: A Neurodegenerative Disease That’s Different from AD
  • He Jincai
    Chief Physician of the Department of Neurology at the First Affiliated Hospital of Wenzhou Medical University.
    2022-06-17
    The Importance of AD’s Early Prevention and Relevant Interventions
  • Li Yanfeng
    Chief Physician of the Department of Neurology at Peking Union Medical College Hospital.
    2022-06-17
    Infection, Inflammation and Alzheimer's Disease: Starting with COVID-19
  • 1
  • 2
  • 3
Prev
  • GV-971

    New hope for treating Alzheimer's disease worldwide

    img1.jpg
    webcode.png
  • Contact us

    Address: 421 Newton Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, China

    Phone: 021-50540520

  • Quick Links
    • Home
    • Contact Us
    • Scientific Research Information
    • Pharmacovigilance
    • News Reports
    • Company Website

Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

The information on this website is provided as knowledge only and shall not replace medical advice and medical consultation provided by physicians or other qualified healthcare professionals. The information on this website shall not be used for disease diagnosis.

©2022 GreenValley Inc.beian.png 沪公网安备31011502018352号沪ICP备2021021810号-3  Powered by Yongsy

Copyright Notice Legal Notices Terms of use